Cargando…
Drug-Induced Liver Injury by Glatiramer Acetate Used for Treatment of Multiple Sclerosis: A Case Report
Glatiramer acetate (GA, Copaxone) is an approved drug for the treatment of relapsing–remitting multiple sclerosis. Most common side effects observed with GA are local injection site reactions, which can include pain, swelling, or redness. However, systemic adverse event such as hepatotoxicity relate...
Autores principales: | Onmez, Attila, Eminler, Ahmet Tarik, Ergenç, Hasan, Baykara, Meltem, Uslan, Ihsan, Tamer, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528838/ https://www.ncbi.nlm.nih.gov/pubmed/26425591 http://dx.doi.org/10.1177/2324709613517493 |
Ejemplares similares
-
Bilateral Choroidal Metastases from Lung Adenocarcinoma: A Case Report
por: Ergenc, Hasan, et al.
Publicado: (2016) -
Glatiramer acetate in the treatment of multiple sclerosis
por: Tselis, Alex, et al.
Publicado: (2007) -
The role of glatiramer acetate in the early treatment of multiple sclerosis
por: Brandes, David W
Publicado: (2010) -
Spasticity in multiple sclerosis and role of glatiramer acetate treatment
por: Meca-Lallana, Jose Eustasio, et al.
Publicado: (2015) -
Adherence to glatiramer acetate treatment for multiple sclerosis: the Brazilian experience
por: de Oliveira, Tatiana de Melo Gomes, et al.
Publicado: (2008)